<DOC>
	<DOCNO>NCT01376245</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety fluticasone furoate/vilanterol Inhalation Powder compare placebo 24 week treatment period subject Asian ancestry Chronic Obstructive Pulmonary Disease ( COPD ) .</brief_summary>
	<brief_title>A 24-week Study Fluticasone Furoate/Vilanterol Inhalation Powder Subjects Asian Ancestry With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>COPD diagnosis define ATS ( American Thoracic Society ) / ERS ( European Respiratory Society ) Subjects Asian ancestry Valid inform consent Current former smoker &gt; = 2 modified Medical Research Council Dyspnea Scale Screening Pregnancy A current diagnosis asthma alpha1antitrypsin deficiency underlie cause COPD Other active , respiratory disorder Have lung volume reduction surgery within 12 month prior Screening A chest Xray CT ( Computerised Tomography ) scan reveals evidence clinical significant abnormality believe due presence COPD Poorly control COPD : acute worsen COPD manage corticosteroid , antibiotic , treatment prescribe physician 6 week prior Screening , require hospitalisation due poorly control COPD 12 week prior Screening Lower respiratory tract infection require antibiotic within 4 week prior Screening Other disease abnormality , opinion investigator , would put safety subject risk study would affect safety efficacy analysis disease/condition exacerbate study Subject carcinoma complete remission least 5 year , carcinoma situ cervix , squamous cell carcinoma basal cell carcinoma skin would exclude subject consider cure within 5 year since diagnosis . Subject history hypersensitivity study medication component inhalation powder . Subject history severe milk protein allergy , opinion investigator , contraindicate subject 's participation also exclude . Subjects know suspected history alcohol drug abuse within last 2 year prior Screening Subjects medically unable withhold albuterol , ipratropium 4 hr and/or theophylline 12 hr prior spirometry test . Subjects use list prohibit medication specify study protocol , include limited traditional herbal medication treatment COPD Subject require longterm oxygen therapy nocturnal oxygen therapy great 12 hour day Pulmonary rehabilitation : subject maintenance phase exclude . Noncompliance Questionable validity Informed Consent Prior use study medication investigational drug Affiliation investigator site</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>